Our Process The goal of LAB150 is to develop new treatments and cures for serious and debilitating diseases. We are creating a new blueprint for translating academic research into market-ready products for the benefit of Canadians and indeed people everywhere.Innovators who choose to work with LAB150 don’t go it alone. When we take a technology into our portfolio, we provide all of the services needed to take it from bench to commercialization, covering every aspect of the early-stage drug discovery cycle.Services We ProvideLAB150 helps innovators access a wide range of drug discovery and development capabilities, including:Target Identification and ValidationScreening and Hit IdentificationTesting Novel Therapeutics in In-Vivo ModelsDrug Metabolism and PharmacokineticsMedicinal ChemistryProteomics and Metabolomics Submission ProcessInterested Innovators affiliated with TIAP’s Member Institutions can express interest to participate in LAB150 by emailing info@lab150.comAfter extensive collaborative discussions, and if the project is selected for further review, the Innovator will be invited to submit a Statement of InterestLAB150 will conduct technical, market and intellectual property due diligence, and together with the Innovator collaboratively prepare project plan and budgetsThe Innovator is invited to make a formal presentation to the LAB150 Joint Steering Committee who subsequently makes the final admission decisionProject agreements are prepared and the project is launched

Our Process

The goal of LAB150 is to develop new treatments and cures for serious and debilitating diseases. We are creating a new blueprint for translating academic research into market-ready products for the benefit of Canadians and indeed people everywhere.

Innovators who choose to work with LAB150 don’t go it alone. When we take a technology into our portfolio, we provide all of the services needed to take it from bench to commercialization, covering every aspect of the early-stage drug discovery cycle.

Services We Provide

LAB150 helps innovators access a wide range of drug discovery and development capabilities, including:

Target Identification and Validation
Screening and Hit Identification
Testing Novel Therapeutics in In-Vivo Models
Drug Metabolism and Pharmacokinetics
Medicinal Chemistry
Proteomics and Metabolomics

 Submission Process

  • Interested Innovators affiliated with TIAP’s Member Institutions can express interest to participate in LAB150 by emailing info@lab150.com
  • After extensive collaborative discussions, and if the project is selected for further review, the Innovator will be invited to submit a Statement of Interest
  • LAB150 will conduct technical, market and intellectual property due diligence, and together with the Innovator collaboratively prepare project plan and budgets
  • The Innovator is invited to make a formal presentation to the LAB150 Joint Steering Committee who subsequently makes the final admission decision
  • Project agreements are prepared and the project is launched